BOB体育

Skip to main content
(352) 294-5000

Torge Rempe, MD, PhD : Research

Neurologist

Additional languages:
Spanish,
German
Photo of Torge Rempe
(352) 294-5000 MyUFHealth

Research at a glance

Top areas of exploration

  • Autoantibodies , 6 publications
  • Myelin-Oligodendrocyte Glycoprotein , 4 publications
  • Immunologic Factors , 4 publications
  • Leukoencephalopathy, Progressive Multifocal , 4 publications

Research activity

25 publications

384 citations

Why is this important?

Active clinical trials

SANOFI 16035 PERSEUS

Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive multiple sclerosis (PPMS) Secondary Objectives: To evaluate efficacy of SAR442168 compared to placebo on clinical鈥�

Investigator
Torge Rempe
Status
Accepting Candidates
Ages
18 Years - 55 Years
Sexes
All
TREAT-MS

FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has begun. It is unclear if, in the relapsing phase, there is an advantage of early鈥�

Investigator
Torge Rempe
Status
Accepting Candidates
Ages
18 Years - 60 Years
Sexes
All

My publications

25 publications

2023

Progressive multifocal leukoencephalopathy without overt immunosuppression.

Medicine

鈥�

2022

A Comparison of Pediatric- and Adult-Onset Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder: A Review of Clinical and Radiographic Characteristics.

Journal of child neurology

鈥�

2022

Longitudinal evaluation of neurologic-post acute sequelae SARS-CoV-2 infection symptoms.

Annals of clinical and translational neurology

鈥�

2022

Therapeutic Advances in Multiple Sclerosis.

Frontiers in neurology

鈥�

2021

Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.

Multiple sclerosis and related disorders

鈥�